Evidence map›Paper›PMID 42242215›Full record

ArticleStem cell reports2026

PCBP1 orchestrates amino acid metabolism burst during the naïve-to-primed pluripotency transition.

Evgeny I Bakhmet, Evgeniy V Potapenko, Oleg Y Shuvalov, Arseniy A Lobov, Egor A Repkin, Daria V Kriger, Nadezhda E Vorobyeva, Alexey N Korablev, Anna S Zinovyeva, Andrey A Kuzmin and 5 more

Abstract read
In one paragraph

Article in Stem cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Evgeny I BakhmetPluripotency Dynamics Group, Laboratory of the Molecular Biology of Stem Cells, Institute of Cytology, Russian Academy of Sciences, St-Petersburg 194064, Russia. Electronic address: e.bakhmet@incras.ru.
Evgeniy V PotapenkoLaboratory of the Molecular Biology of Stem Cells, Institute of Cytology, Russian Academy of Sciences, St-Petersburg 194064, Russia.
Oleg Y ShuvalovOncopharmacology Group, Laboratory of Regulation of Gene Expression, Institute of Cytology, Russian Academy of Sciences, St-Petersburg 194064, Russia.
Arseniy A LobovLaboratory of Regenerative Biomedicine, Institute of Cytology, Russian Academy of Sciences, St-Petersburg 194064, Russia.
Egor A RepkinResource Centre for Molecular and Cell Technologies, Research Park, St-Petersburg State University, St-Petersburg 199034, Russia.
Daria V KrigerRegulated Proteolysis Group, Laboratory of Cell Metabolism and Signaling, Institute of Cytology, Russian Academy of Sciences, St-Petersburg 194064, Russia.
Nadezhda E VorobyevaGroup of Transcriptional Complexes Dynamics, Institute of Gene Biology, Russian Academy of Sciences, Moscow 119334, Russia.
Alexey N KorablevDepartment of Molecular Mechanisms of Development, Institute of Cytology and Genetics, Russian Academy of Sciences, Siberian Branch, Novosibirsk 630090, Russia.
Anna S ZinovyevaPluripotency Dynamics Group, Laboratory of the Molecular Biology of Stem Cells, Institute of Cytology, Russian Academy of Sciences, St-Petersburg 194064, Russia.
Andrey A KuzminLaboratory of the Molecular Biology of Stem Cells, Institute of Cytology, Russian Academy of Sciences, St-Petersburg 194064, Russia.
Nikolay D AksenovDepartment of Intracellular Signaling and Transport, Institute of Cytology, Russian Academy of Sciences, St-Petersburg 194064, Russia.
Arthur T KopylovLaboratory of Structural Proteomics, V.N. Orekhovich Institute of Biomedical Chemistry, Russian Academy of Sciences, Moscow 119121, Russia.
Guangming WuDepartment of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster 48149, Germany.
Hans R SchölerDepartment of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster 48149, Germany.
Alexey N TomilinLaboratory of the Molecular Biology of Stem Cells, Institute of Cytology, Russian Academy of Sciences, St-Petersburg 194064, Russia. Electronic address: a.tomilin@incras.ru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Embryo implantation is accompanied by the naïve-to-primed pluripotency state transition in epiblast cells-the process involving proliferation and anabolic boost, needed for extensive embryo growth. Here, we show that Pcbp1 knockout leads to embryo growth arrest shortly after implantation. By modeling the naïve-to-primed pluripotency transition in vitro, we observe impaired proliferation and induction of apoptosis in cells deficient for PCBP1. Using multi-omics approaches, we reveal a crucial role for PCBP1 in driving a transcriptional burst of numerous genes involved in the import and the de novo synthesis of essential and conditionally essential amino acids. PCBP1 deficiency is consequently associated with a slowdown in protein biosynthesis, which explains the early lethality of the knockout embryos. Our findings thus uncover the molecular mechanisms underlying anabolic changes during the naïve-to-primed pluripotency transition and highlight the essential role of PCBP1 in this critical process.

Indexed as

Amino AcidsDNA-Binding ProteinsHeterogeneous-Nuclear RibonucleoproteinsPluripotent Stem CellsRNA-Binding ProteinsAnimalsApoptosisCell DifferentiationCell ProliferationEmbryonic DevelopmentGene Expression Regulation, DevelopmentalMiceMice, KnockoutAmino AcidsDNA-Binding ProteinsHeterogeneous-Nuclear RibonucleoproteinsPcbp1 protein, mouseRNA-Binding Proteinsamino acid metabolismembryogenesisEpiSCESCmurine developmentPCBP1pluripotency

Identifiers

PMID42242215
PMCPMC13385435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.